Silenor® (doxepin) | For People with Insomnia who Have Difficulty Staying Asleep
Links shared publicly online about this topic.
- 836total visits
Silenor® (doxepin) | For People with Insomnia who Have Difficulty Staying Asleep
View full resource at silenor.com
Tags: Sleep Disorder, Insomnia, Drug, FDA
Most Recently Shared on September 30, 2010 at 1:12 pm By:
Insomnia: "New" drug Silenor (Somaxon Pharm.) available. Savings card for $25 off 3 refills available online http://www.silenor.com #drugs
Somaxon and Paladin Announce Silenor Ex-US Collaboration - Drugs.com MedNews
drugs.com — “Paladin Labs to Commercialize Silenor in Canada, South America and Africa Somaxon to Receive Up-front and Milestone Payments of Up to US 129 million Paladin Lab” View full resource at drugs.com
Most Recently Shared on June 8, 2011 at 3:13 pm By:
Drugs and Devices OW OW Health
Somaxon and Paladin Announce Silenor Ex-US Collaboration: Paladin Labs to Commercialize Silenor in Canada,... http://bit.ly/lC3NrM #drug
Paladin to commercialize Silenor for treatment of insomnia in Canada, South America and Africa
news-medical.net — “Somaxon Pharmaceuticals, Inc. and Paladin Labs Inc. today announced that they have entered into an exclusive collaboration under which Paladin will commercialize Silenor® (doxepin) for the treatment of insomnia characterized by difficulty with sleep maintenance in Canada, South America and Africa.” View full resource at news-medical.net
Most Recently Shared on June 8, 2011 at 2:24 pm By:
Paladin to commercialize Silenor for treatment of insomnia in Canada, South America and Africa: Somaxon Pharmace... http://bit.ly/iseLpT
Somaxon faces swift attacks from generics - SignOnSanDiego.com
signonsandiego.com — “Breaking San Diego news from The San Diego Union-Tribune: Classifieds, entertainment, sports, hotels and visitor information” View full resource at signonsandiego.com
Most Recently Shared on June 1, 2011 at 3:55 pm By:
John Carroll Health Communicator
8 months after an approval, Somaxon faces generic comp for Silenor? http://bit.ly/iOo0ei
Somaxon Pharmaceuticals Announces Presentation Of Silenor(R) Data At National Medical Meetings
medicalnewstoday.com — “Somaxon Pharmaceuticals, Inc. (NASDAQ: SOMX), a specialty pharmaceutical company, today announced that it will present new analyses of data from the Silenor Phase 3 clinical development program at” View full resource at medicalnewstoday.com
Most Recently Shared on May 18, 2011 at 3:05 pm By:
Somaxon Pharmaceuticals Announces Presentation Of Silenor(R) Data At National Medical Meetings http://mnt.to/3W3h #sleep
Somaxon Pharmaceuticals Announces Presentation of Silenor® Data at National Medical Meetings 17.05.2011 | Nachricht | finanzen.net
finanzen.net — “Somaxon Pharmaceuticals Announces Presentation of Silenor® Data at National Medical Meetings 17.05.2011 | Nachricht | finanzen.net” View full resource at finanzen.net
Most Recently Shared on May 17, 2011 at 8:33 pm By:
Somaxon Pharmaceuticals Announces Presentation of Silenor® Data at National Medical Meetings: Somaxon Pharmaceut... http://bit.ly/kyPO9T
Somaxon Pharma gets new insomnia drug patent - Bloomberg
bloomberg.com — “SAN DIEGO (AP) --" Somaxon Pharmaceuticals Inc. said Tuesday it received a new patent on its insomnia drug Silenor, extending its exclusivity on the drug.” View full resource at bloomberg.com
Most Recently Shared on February 23, 2011 at 2:56 am By:
Drugs and Devices OW OW Health
Somaxon Pharma gets new insomnia drug patent - Bloomberg: Somaxon Pharma gets new insomnia drug patentBloo... http://bit.ly/h8lwip #drug
Somaxon announces nonreceipt of Paragraph IV certification for generic Silenor ANDA
news-medical.net — “Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today announced that the website of the U.S. Food and Drug Administration (FDA) indicates that an Abbreviated New Drug Application (ANDA) for a generic version of Silenor® (doxepin) 3 mg and 6 ” View full resource at news-medical.net
Most Recently Shared on October 19, 2010 at 4:35 am By:
Somaxon announces nonreceipt of Paragraph IV certification for generic Silenor ANDA: Somaxon Pharmaceuticals, Inc.... http://bit.ly/bMu7t0
SILENOR - New Product Releases - MPR
empr.com — “Treatment of insomnia characterized by difficulty with sleep maintenance.” View full resource at empr.com
Most Recently Shared on September 24, 2010 at 1:59 pm By:
MPR News: SILENOR: Doxepin (as HCl) 3mg, 6mg; tabs. http://bit.ly/9u7IuT
Somaxon Pharmaceuticals Announces Commercial Availability of
bioresearchonline.com — “Somaxon Pharmaceuticals Announces Commercial Availability Of Silenor” View full resource at bioresearchonline.com
Most Recently Shared on September 7, 2010 at 6:16 pm By:
Urology & Nephrology OW Health
Somaxon Pharmaceuticals Announces Commercial Availability Of Silenor: Somaxon Pharmaceuticals, Inc. (Nasdaq: SOMX)... http://bit.ly/crXWbY
Silenor available for sleep maintenance insomnia - MPR
empr.com — “Somaxon announced that Silenor (doxepin tablets) has been made available for the treatment of insomnia characterized by difficulty with sleep maintenance.” View full resource at empr.com
Most Recently Shared on September 7, 2010 at 5:16 pm By:
MPR News: Silenor available for sleep maintenance insomnia: Somaxon announced that Silenor (doxepin tablets) has b... http://bit.ly/doUFCL
Somaxon's Silenor now commercially available in U.S.
news-medical.net — “Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company, today announced that Silenor® (doxepin) now is commercially available by prescription in the United States. Somaxon has implemented a wholesale and retail stocking program to disseminate Silenor 3 mg and 6 mg dosepacks to pharmacies across the United States. Silenor is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance.” View full resource at news-medical.net
Most Recently Shared on September 7, 2010 at 1:47 pm By:
Somaxon's Silenor now commercially available in U.S.: Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical co... http://bit.ly/cddJoz
New insomnia drug in the pipeline
insomnialand.com — “We know that for some, insomnia medication is a necessity – although many complain about the side-effects; from unusual behavior to grogginess the next day. Silenor, which has recently been approved by the FDA (after two previous rejections) works differently” View full resource at insomnialand.com
Most Recently Shared on March 24, 2010 at 12:50 pm By:
New insomnia drug in the pipeline: http://bit.ly/apv8Cq
Somaxon Announces FDA Approval of Silenor (doxepin) for the Treatment of Insomnia
drugs.com — “Silenor (doxepin) is used to treat insomnia characterized by difficulty with sleep maintenance. Includes Silenor side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on March 23, 2010 at 1:23 am By:
Somaxon Announces FDA Approval of Silenor (doxepin) for the Treatment of Insomnia - http://bit.ly/b7K3PK
Somaxon Announces FDA Approval Of Silenor(R) (doxepin) For The Treatment Of Insomnia
medicalnewstoday.com — “Somaxon Pharmaceuticals, Inc. (Nasdaq: SOMX) today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for Silenor® (doxepin) for the treatme” View full resource at medicalnewstoday.com
Most Recently Shared on March 20, 2010 at 5:37 am By:
Somaxon Announces FDA Approval Of Silenor(R) (doxepin) For The Treatment Of Insomnia Somaxon Pharmaceuticals, Inc. (N.. http://bit.ly/9eRDbZ
Advertisement
